HIND: Vyome Holdings Inc Company Short-Term Debt
The price chart for Vyome Holdings Inc (HIND) reflects the dynamics of a biopharmaceutical business developing unique treatments for fungal skin lesions. The current figure for separate short-term debt stands at 0.00. The company is losing market share in the bandaging segment due to the expansion of injectable weight-loss drugs. Growth prospects rely on combating antibiotic resistance through new anti-inflammatory developments.
Metric breakdowns and analytics for Vyome Therapeutics (HIND)
- current quotes and average value forecast:
- market capitalization information:
- shareholders' equity book value data:
- debt and liquidity data:
Total Debt to Capital Vyome Holdings Inc|HIND - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Vyome Holdings Inc|HIND - Company Total Debt|Debt to Book Capitalization Ratio Vyome Holdings Inc.|HIND - Company Long-Term Liabilities|Company Current Liabilities Vyome Holdings|Quick Liquidity reshapelifesciences.com
- net income and valuation multiples indicators:
Initial company analysis:HIND - Vyome Holdings
This indicator measures the aggregate of all financial obligations of Vyome Holdings Inc (HIND) due within twelve months, allowing for an assessment of the risk of a liquidity gap. By analyzing the volume of short-term debt capital, an investor determines management's ability to fund the development of various antimicrobial therapies, where liquidity control is critical to ensuring the stability of a diversified clinical trial portfolio.
Competitor analysis
ARGX - Company Short-Term Debt|Company Short-Term Loans and Borrowings BNTX (BioNTech Inc.)|Abivax (ABVX) - Company Short-Term Debt|Company Current Liabilities ADMA Corp|PTGX (Protagonist Therapeutics) - Company Short-Term Debts|Company Short-Term Debts immunovant.com|Company Current Liabilities KNSA (Kiniksa)|GRFS (Grifols SA) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ADPT (Adaptive Biotechnologies Corp)|Short-Term Debt Volume Celldex Corp (CLDX)|AUPH - Company Short-Term Debt|biocryst.com (BCRX) - Company Current Liabilities|Vera Therapeutics (VERA) - Company Short-Term Debt|Company Current Liabilities Dianthus Therapeutics Inc|Company Current Liabilities PHVS|Company Short-Term Debts abcellera.com|Company Short-Term Debt Tourmaline Bio, Inc. (TRML)|precigen.com - Company Short-Term Indebtedness|Company Short-Term Debts PHAR (Pharming Group)|Nektar Therapeutics Inc (NKTR) - Short-Term Debt|UPB: Company Current Liabilities|ZBIO: Company Short-Term Debt|IMNM (Immunome, Inc.) - Company Current Liabilities|Short-Term Debt gossamerbio.com (GOSS)|Company Short-Term Debt KalVista Pharmaceuticals, Inc.|Short-Term Debt Septerna, Inc. SEPN|Company Short-Term Debt Pieris Pharmaceuticals Inc (PVLA)|Company Current Liabilities Savara Pharma SVRA|Company Short-Term Debts RIGL (Rigel Pharmaceuticals)|anaptysbio.com (ANAB) - Short-Term Debt|ATXS: Company Current Liabilities|Company Short-Term Loans and Borrowings ENGN (enGene Holdings Inc)|RAPT: Company Short-Term Debts|Aerovate Therapeutics - Company Short-Term Loans and Borrowings|Company Short-Term Debt Aclaris Therapeutics|Short-Term Debt kyvernatx.com KYTX|Company Short-Term Debt Tiziana Life Sciences Ltd (TLSA)|Company Short-Term Debt CABA (Cabaletta Bio Inc.)|Company Short-Term Debts VTYX (Ventyx Bio)|THTX: Company Short-Term Indebtedness|Avalo Therapeutics, Inc - Company Short-Term Debts|Short-Term Debt Volume eledon.com ELDN|Agenus Inc. (AGEN) - Company Short-Term Debt|Company Short-Term Indebtedness CLYM|ZURA (Zura Bio) - Company Short-Term Debts|ATYR - Short-Term Indebtedness|Company Short-Term Debt Adagene (ADAG)|Short-Term Debt Volume ikenaoncology.com|Shattuck Labs - Company Current Liabilities|Company Short-Term Loans and Borrowings EQ|Connect Pharma - Company Short-Term Debts|Short-Term Debt Volume Immunic, Inc. IMUX|atarabio.com (ATRA) - Company Short-Term Debt|Company Short-Term Indebtedness IFRX|XFOR (X4 Pharmaceuticals, Inc.) - Company Short-Term Debts|Company Current Liabilities Adicet (ACET)|Company Short-Term Debts CELU|INMB (INmune Bio Corporation) - Company Short-Term Loans and Borrowings|Company Short-Term Debts BRNS (Barinthus Biotherapeutics)|Short-Term Debt Volume kezarlifesciences.com (KZR)|SABS - Company Short-Term Debt|AKTX (Akari Therapeutics PLC) - Company Short-Term Indebtedness|ENLV: Company Short-Term Debts|Company Short-Term Indebtedness QTTB|Company Short-Term Debt GeoVax Labs, Inc.|edesabiotech.com - Current Liabilities|Company Short-Term Debts IBIO|CARM (carismatx.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debts XTLB (XTL Biopharmaceuticals, Ltd.)|Company Short-Term Debts Bolt Biotherapeutics Inc. BOLT|HCWB - Company Short-Term Debt|Company Short-Term Loans and Borrowings APVO (Aptevo Therapeutics)|AIM ImmunoTech Inc. (AIM) - Company Short-Term Debt|Company Current Liabilities Aditxt, Inc.|GRI (GRI Bio Corp) - Company Short-Term Debts|Company Short-Term Debts XORTX Corp|Company Current Liabilities REVB (Revelation Biosciences)|INDP (indaptusrx.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debts SCNI (Scinai Immunotherapeutics Ltd.)|Short-Term Debt Volume CalciMedica Inc (CALI)|AFMD - Company Short-Term Debt|Allakos Inc. (ALLK) - Company Current Liabilities|hookipapharma.com (HOOK) - Company Short-Term Debt|Company Current Liabilities IGM Biosciences|Company Current Liabilities ITOS|Company Short-Term Debts Ocean Biomedical Inc|Company Short-Term Debt TC BioPharm (Holdings) PLC (TCBP)|Third Harmonic Bio Inc - Company Short-Term Indebtedness